Related references
Note: Only part of the references are listed.Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
Patricia R. M. Rocco et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
J. McCoy et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
Yuanyuan Qiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
Tianling Ou et al.
PLOS PATHOGENS (2021)
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19
Hatem Elalfy et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
Fei Li et al.
NATURE COMMUNICATIONS (2021)
Response to Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice''
Cristina Pindado-Ortega et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
Flavio A. Cadegiani et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical)
Flavio A. Cadegiani et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Potential risk for developing severe COVID-19 disease among anabolic steroid users
Flavio Cadegiani et al.
BMJ CASE REPORTS (2021)
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells
Feng Qu et al.
INVESTIGATIONAL NEW DRUGS (2020)
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
M. Montopoli et al.
ANNALS OF ONCOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
Carlos Gustavo Wambier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer
Tie Zhou et al.
EUROPEAN JOURNAL OF CANCER (2020)
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
Carlos Gustavo Wambier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Male balding is a major risk factor for severe COVID-19
Justin Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Alopecia and grey hair are associated with COVID-19 Severity
Paulo Muller Ramos et al.
EXPERIMENTAL DERMATOLOGY (2020)
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
A. Goren et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
Ryan M. Samuel et al.
CELL STEM CELL (2020)
Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020
Flavia Riccardo et al.
EUROSURVEILLANCE (2020)
Brazilian blood donation eligibility criteria for dermatologic patients
Carlos Gustavo Wambier et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2012)
Androgen deprivation modulates the inflammatory response induced by irradiation
Chun-Te Wu et al.
BMC CANCER (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Flutamide protects against trauma-hemorrhage-induced liver injury via attenuation of the inflammatory response, oxidative stress, and apopotosis
Wen-Hong Kan et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Androgens modulate the inflammatory response during acute wound healing
SC Gilliver et al.
JOURNAL OF CELL SCIENCE (2006)